Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results
Director departure
Appointed director

Acer Therapeutics Inc. (ACER) Create: Alert

All | News | Filings
Date FiledTypeDescription
03/16/2023 4 Quartel Adrian W (Chief Medical Officer) has filed a Form 4 on Acer Therapeutics Inc.
Txns: Granted 30,000 options to buy @ $1.67, valued at $50.1k
03/16/2023 4 Paul Bernard H (Chief People Officer) has filed a Form 4 on Acer Therapeutics Inc.
Txns: Granted 30,000 options to buy @ $1.67, valued at $50.1k
03/16/2023 4 PALMIN HARRY S (CFO) has filed a Form 4 on Acer Therapeutics Inc.
Txns: Granted 30,000 options to buy @ $1.67, valued at $50.1k
03/16/2023 4 Klopp John Michael (Chief Technical Officer) has filed a Form 4 on Acer Therapeutics Inc.
Txns: Granted 30,000 options to buy @ $1.67, valued at $50.1k
03/16/2023 4 Joseph Donald (Chief Legal Officer and Secy) has filed a Form 4 on Acer Therapeutics Inc.
Txns: Granted 30,000 options to buy @ $1.67, valued at $50.1k
03/16/2023 4 Hayden Tanya (COO) has filed a Form 4 on Acer Therapeutics Inc.
Txns: Granted 30,000 options to buy @ $1.67, valued at $50.1k
03/16/2023 4 GRIFFIN MICHELLE RENEE (Director) has filed a Form 4 on Acer Therapeutics Inc.
Txns: Granted 20,000 options to buy @ $1.67, valued at $33.4k
03/16/2023 4 DUNN JOHN MICHAEL (Director) has filed a Form 4 on Acer Therapeutics Inc.
Txns: Granted 20,000 options to buy @ $1.67, valued at $33.4k
03/16/2023 4 Davis Jefferson E (Chief Business Officer) has filed a Form 4 on Acer Therapeutics Inc.
Txns: Granted 30,000 options to buy @ $1.67, valued at $50.1k
03/16/2023 4 ASELAGE STEVE (Director) has filed a Form 4 on Acer Therapeutics Inc.
Txns: Granted 20,000 options to buy @ $1.67, valued at $33.4k
03/16/2023 4 Amello Jason (Director) has filed a Form 4 on Acer Therapeutics Inc.
Txns: Granted 20,000 options to buy @ $1.67, valued at $33.4k
12/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/22/2022 4 Hayden Tanya (COO) has filed a Form 4 on Acer Therapeutics Inc.
Txns: Granted 25,000 options to buy @ $1.76, valued at $44k
02/23/2022 4 Quartel Adrian W (Chief Medical Officer) has filed a Form 4 on Acer Therapeutics Inc.
Txns: Granted 200,000 options to buy @ $2.55, valued at $510k
01/21/2022 4 Paul Bernard H (Chief People Officer) has filed a Form 4 on Acer Therapeutics Inc.
Txns: Granted 25,000 options to buy @ $2.21, valued at $55.3k
01/19/2022 4 Seibt Matthew (Chief Commercial Officer) has filed a Form 4 on Acer Therapeutics Inc.
Txns: Granted 25,000 options to buy @ $2.21, valued at $55.3k
01/19/2022 4 Schelling Chris (President & CEO) has filed a Form 4 on Acer Therapeutics Inc.
Txns: Granted 50,000 options to buy @ $2.21, valued at $110.5k
01/19/2022 4 PALMIN HARRY S (Chief Opp. and Financial Offr) has filed a Form 4 on Acer Therapeutics Inc.
Txns: Granted 25,000 options to buy @ $2.21, valued at $55.3k
01/19/2022 4 Klopp John Michael (Chief Technical Officer) has filed a Form 4 on Acer Therapeutics Inc.
Txns: Granted 25,000 options to buy @ $2.21, valued at $55.3k
01/19/2022 4 Joseph Donald (Chief Legal Officer and Secy) has filed a Form 4 on Acer Therapeutics Inc.
Txns: Granted 25,000 options to buy @ $2.21, valued at $55.3k
01/19/2022 4 GRIFFIN MICHELLE RENEE (Director) has filed a Form 4 on Acer Therapeutics Inc.
Txns: Granted 18,500 options to buy @ $2.21, valued at $40.9k
01/19/2022 4 DUNN JOHN MICHAEL (Director) has filed a Form 4 on Acer Therapeutics Inc.
Txns: Granted 18,500 options to buy @ $2.21, valued at $40.9k
01/19/2022 4 Davis Jefferson E (Chief Business Officer) has filed a Form 4 on Acer Therapeutics Inc.
Txns: Granted 25,000 options to buy @ $2.21, valued at $55.3k
01/19/2022 4 ASELAGE STEVE (Director) has filed a Form 4 on Acer Therapeutics Inc.
Txns: Granted 18,500 options to buy @ $2.21, valued at $40.9k
01/19/2022 4 Amello Jason (Director) has filed a Form 4 on Acer Therapeutics Inc.
Txns: Granted 18,500 options to buy @ $2.21, valued at $40.9k
12/13/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/05/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/20/2021 4 Seibt Matthew (Chief Commercial Officer) has filed a Form 4 on Acer Therapeutics Inc.
Txns: Granted 20,000 options to buy @ $3.85, valued at $77k
01/20/2021 4 Schelling Chris (President & CEO) has filed a Form 4 on Acer Therapeutics Inc.
Txns: Granted 40,000 options to buy @ $3.85, valued at $154k
01/20/2021 4 PALMIN HARRY S (Chief Opp. and Financial Offr) has filed a Form 4 on Acer Therapeutics Inc.
Txns: Granted 60,000 options to buy @ $3.85, valued at $231k
01/20/2021 4 Klopp John Michael (Chief Technical Officer) has filed a Form 4 on Acer Therapeutics Inc.
Txns: Granted 20,000 options to buy @ $3.85, valued at $77k
01/20/2021 4 Joseph Donald (Chief Legal Officer and Secy) has filed a Form 4 on Acer Therapeutics Inc.
Txns: Granted 60,000 options to buy @ $3.85, valued at $231k
01/20/2021 4 GRIFFIN MICHELLE RENEE (Director) has filed a Form 4 on Acer Therapeutics Inc.
Txns: Granted 15,000 options to buy @ $3.85, valued at $57.8k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy